Henrik Molin
CEO
Replay available
Physitrack PLC (STO: PTRK) Q3 2025 earnings conference call, held 2025-10-21. Replay captured from the company's public earnings webcast.

CEO
CFO
hello and welcome to fizz track's q4 2024 results webcast i am henrik molin and i'm joined today by fizz track's fantastic cfo charlotte goodwin we'll be taking you through our fourth quarter performance providing key business updates across our our two divisions and you'll be followed by charlotte's deep dive into our financial results and after that we'll revisit our strategy and outlook for 2025 and then we'll open up for q a Now, if you're joining us live, you're via Zoom today, you can submit your questions using the chat function on your panel and we'll address as many as possible of these questions towards the end of the session. So let's dive in. We've had strong momentum in Q4, setting us up for an exciting 2025. Some key highlights from the quarter which you can see here on the slide. So quarterly revenue growth of 14%, bringing us to an analysed run rate of 16.7 million euros. Year-on-year recurring revenue growth sits at 18%. We're now at a 13.3 million analysed run rate. Adjusted EBITDA margin improved to 24%, delivering 3.9 million in adjusted EBITDA for the full fiscal year. And importantly, just as we said we do, we return to cash flow positivity, generating a net of 0.4 million in cash during the quarter. Now let's take a closer look at our two business divisions, Life Care and Wellness, starting with Life Care. So a reminder, our Life Care division is focused on empowering healthcare providers with tools to help patients recover faster and more effectively using our digital platform and now represents 65% of our total business. Some highlights here. Quarterly revenue growth was 14% with annualized revenue now at 11.1 million euros. Adjusted EBITDA was 4.8 million, reflecting a 46% margin. We saw 22% year-over-year revenue growth with recurring reven...